Heteroatoms-containing tricyclic compounds

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Silicon containing doai

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514291, 540452, 540456, A61K 31395, A61K 31695, C07D48916, C07F 718

Patent

active

059122382

ABSTRACT:
The invention concerns the compounds of formula I ##STR1## wherein the substituents have various significances. They are prepared by several processes including epimerizing replacement, treatment with cyanogen bromide or thiophosgene, treatment with an acid having a non-nucleophilic anion, treatment with dimethylsulfoxide and acetic anhydride, acylation, treatment with an oxalyl derivative and ammonia, methylation, oxidation, deprotection and protection. They possess interesting pharmacological activity as antiinflammatory, immunosuppressant, antiproliferative and chemotherapeutic drug resistance reversing agents.

REFERENCES:
patent: 5064835 (1991-11-01), Bochis et al.
patent: 5143918 (1992-09-01), Bochis et al.
patent: 5162334 (1992-11-01), Goulet et al.
patent: 5189042 (1993-02-01), Goulet et al.
patent: 5208228 (1993-05-01), Ok et al.
patent: 5296489 (1994-03-01), Donald et al.
J. Am. Chem. Soc. 1987, 109, 5031-5033.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Heteroatoms-containing tricyclic compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Heteroatoms-containing tricyclic compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heteroatoms-containing tricyclic compounds will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-402589

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.